AAHIVM Encouraged by TMC125 Approval
New HIV Medication Could Offer More Options for Treatment-Experienced Patients WASHINGTON, Feb. 4 /PRNewswire/ -- The American Academy of HIV Medicine (AAHIVM), a national organization of HIV-treating physicians, nurse practitioners and physician assistants, pra...FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
- The Prescription Drug User Fee Act (PDUFA) user fee goal date will be January 18, 2008 - YARDLEY, Pa., Sept. 20 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced that the New Drug Application (NDA) for TMC125 (etravirine), an investigational non-nucleosid...FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
- The Prescription Drug User Fee Act (PDUFA) user fee goal date will be January 18, 2008 - YARDLEY, Pa., Sept. 20 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced that the New Drug Application (NDA) for TMC125 (etravirine), an investigational non-nucleosid...New Drugs Show Promise in Fighting Drug-Resistant HIV
... powerful agents to fight the disease to date, are tmc125 (etravirine) and TMC114 (darunavir, also known as ...is the pivotal registration and efficacy trial for tmc125 (it is in a class of HIV drugs called non-nucleosi...found that at the 24th week, patients who received tmc125 in combination with TMC114 achieved superior virol...New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
...o drugs, amongst the most powerful agents to fight the disease to date, are tmc125 (etravirine) and TMC114 (darunavir, also known as Prezista), both made by T...nd placebo controlled -- is the pivotal registration and efficacy trial for tmc125 (it is in a class of HIV drugs called non-nucleoside reverse transcriptase ...